Aurobindo Pharma in Focus on ₹800 Crore Buyback Opportunity

Shares of Aurobindo Pharma are in focus on the National Stock Exchange of India as the company announced a ₹800 crore share buyback, attracting investor attention. The stock is seeing interest as today is the last day to buy shares to be eligible for the buyback record date. Investors who hold the stock before the ex-date can participate in the buyback, which is often offered at a premium price. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.